357 related articles for article (PubMed ID: 21374800)
1. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
Clarke JD; Hsu A; Yu Z; Dashwood RH; Ho E
Mol Nutr Food Res; 2011 Jul; 55(7):999-1009. PubMed ID: 21374800
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.
Myzak MC; Hardin K; Wang R; Dashwood RH; Ho E
Carcinogenesis; 2006 Apr; 27(4):811-9. PubMed ID: 16280330
[TBL] [Abstract][Full Text] [Related]
3. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.
Myzak MC; Karplus PA; Chung FL; Dashwood RH
Cancer Res; 2004 Aug; 64(16):5767-74. PubMed ID: 15313918
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly.
Rajendran P; Delage B; Dashwood WM; Yu TW; Wuth B; Williams DE; Ho E; Dashwood RH
Mol Cancer; 2011 May; 10():68. PubMed ID: 21624135
[TBL] [Abstract][Full Text] [Related]
5. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line.
Herman-Antosiewicz A; Xiao H; Lew KL; Singh SV
Mol Cancer Ther; 2007 May; 6(5):1673-81. PubMed ID: 17513615
[TBL] [Abstract][Full Text] [Related]
6. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention.
Ho E; Clarke JD; Dashwood RH
J Nutr; 2009 Dec; 139(12):2393-6. PubMed ID: 19812222
[TBL] [Abstract][Full Text] [Related]
7. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention.
Wang L; Liu D; Ahmed T; Chung FL; Conaway C; Chiao JW
Int J Oncol; 2004 Jan; 24(1):187-92. PubMed ID: 14654956
[TBL] [Abstract][Full Text] [Related]
8. Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells.
Cho SD; Li G; Hu H; Jiang C; Kang KS; Lee YS; Kim SH; Lu J
Nutr Cancer; 2005; 52(2):213-24. PubMed ID: 16201852
[TBL] [Abstract][Full Text] [Related]
9. Multi-targeted prevention of cancer by sulforaphane.
Clarke JD; Dashwood RH; Ho E
Cancer Lett; 2008 Oct; 269(2):291-304. PubMed ID: 18504070
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane suppresses in vitro and in vivo lung tumorigenesis through downregulation of HDAC activity.
Jiang LL; Zhou SJ; Zhang XM; Chen HQ; Liu W
Biomed Pharmacother; 2016 Mar; 78():74-80. PubMed ID: 26898427
[TBL] [Abstract][Full Text] [Related]
11. The effect of sulforaphane on histone deacetylase activity in keratinocytes: Differences between in vitro and in vivo analyses.
Dickinson SE; Rusche JJ; Bec SL; Horn DJ; Janda J; Rim SH; Smith CL; Bowden GT
Mol Carcinog; 2015 Nov; 54(11):1513-20. PubMed ID: 25307283
[TBL] [Abstract][Full Text] [Related]
12. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases.
Thakur VS; Gupta K; Gupta S
Carcinogenesis; 2012 Feb; 33(2):377-84. PubMed ID: 22114073
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells.
Chiao JW; Chung FL; Kancherla R; Ahmed T; Mittelman A; Conaway CC
Int J Oncol; 2002 Mar; 20(3):631-6. PubMed ID: 11836580
[TBL] [Abstract][Full Text] [Related]
14. Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds.
Nian H; Delage B; Ho E; Dashwood RH
Environ Mol Mutagen; 2009 Apr; 50(3):213-21. PubMed ID: 19197985
[TBL] [Abstract][Full Text] [Related]
15. 3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells.
Beaver LM; Yu TW; Sokolowski EI; Williams DE; Dashwood RH; Ho E
Toxicol Appl Pharmacol; 2012 Sep; 263(3):345-51. PubMed ID: 22800507
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
Abbas A; Hall JA; Patterson WL; Ho E; Hsu A; Al-Mulla F; Georgel PT
Biochem Cell Biol; 2016 Feb; 94(1):71-81. PubMed ID: 26458818
[TBL] [Abstract][Full Text] [Related]
17. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
[TBL] [Abstract][Full Text] [Related]
18. Effects of sulforaphane and 3,3'-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells.
Wong CP; Hsu A; Buchanan A; Palomera-Sanchez Z; Beaver LM; Houseman EA; Williams DE; Dashwood RH; Ho E
PLoS One; 2014; 9(1):e86787. PubMed ID: 24466240
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial.
Zhang Z; Garzotto M; Davis EW; Mori M; Stoller WA; Farris PE; Wong CP; Beaver LM; Thomas GV; Williams DE; Dashwood RH; Hendrix DA; Ho E; Shannon J
Nutr Cancer; 2020; 72(1):74-87. PubMed ID: 31155953
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic mechanism of growth inhibition induced by phenylhexyl isothiocyanate in prostate cancer cells.
Beklemisheva AA; Fang Y; Feng J; Ma X; Dai W; Chiao JW
Anticancer Res; 2006; 26(2A):1225-30. PubMed ID: 16619528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]